PROF SIR MARC FELDMANN AND PROF RAPHAEL MECHOULAM AT THE INTERNATIONAL CANNABIS CONFERENCE IN LEIDEN, HOLLAND. 2018.

PIONEERING SCIENTISTS COMBINING THEIR EXPERIENCE AND EXPERTISE TO CREATE INNOVATIVE TREATMENTS AND THERAPIES

Co-Founded by Prof Sir Marc Feldmann, credited for one of the most important discoveries of modern science and medicine, and Prof Raphael Mechoulam, the Godfather of the Medical Marijuana Industry, CannBioRex is leveraging their combined experience and expertise in looking for orally active and safe counterparts of current standards of care.

TODAY

With combined foundations and expertise in the Medical Marijuana sector stretching back a number of decades, CannBioRex is unique, and our objective is clear - to further develop synthetic pharmaceutical grade cannabinoids to treat conditions associated with arthritis and pain (acute and chronic). Later stage development targets will also include our secondary indications such as diabetes, obesity and other unmet medical needs.